Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

The body's immune system mistakenly produces "autoantibodies," or antibodies that attack its own tissues and proteins. In the case of myasthenia gravis, the body produces autoantibodies that ...

Credit: Dalin Ou via Getty Images. US biotech Merida Biosciences has launched with $121m in Series A financing to develop therapeutics targeting disease-causing antibodies in autoimmune diseases and ...

Global pharmaceutical stocks plunged on the news Wednesday, with U.K.-based AstraZeneca dropping 5% and Swiss drugmaker Novartis losing 3% in early trading on U.S. exchanges. Top U.S. drugmakers, ...

“Many of the most promising new therapies are antibodies, which cannot efficiently reach the brain without a shuttle to get them across the [blood brain barrier],” Austin added. “This ...

2–4 On Sept 1, 2024, vaccination of individuals aged 75–79 years began in England using bivalent prefusion F (pre-F) vaccine (Abrysvo, Pfizer, New York, NY, USA). We conducted an early assessment of ...

ABRYSVO is an unadjuvanted, bivalent vaccine that was designed to ... is a major target of neutralizing antibodies, serving as the basis of Pfizer’s RSV vaccine. Variations in the F protein ...

To start, can you tell us a little about your role at LabGenius Therapeutics and what excites you most about working on automation in antibody discovery? At LabGenius Therapeutics, I’m focused ...

Spanish scientists documented a second so-called class switch in people with "repeated" mRNA COVID jabs, meaning their bodies start churning out two kinds of antibodies that learn to live with ...